MAP4K3 and breast cancer: The calcineurin regulatory subunit PPP3R1 shows elevated expression in ER− breast cancer, whereas positive regulators of Rag C/D, including folliculin complex members FLCN and FNIP1, along with MAP4K3, are decreased in ER− breast cancer patients (Fig. 1C).